Evidence map›Paper›PMID 25491509›Full record

ArticleBMC health services research2014

Perceptions of inhibitors and facilitators for adhering to hypertension treatment among insured patients in rural Nigeria: a qualitative study.

Aina O Odusola, Marleen Hendriks, Constance Schultsz, Oladimeji A Bolarinwa, Tanimola Akande, Akin Osibogun, Charles Agyemang, Gbenga Ogedegbe, Kayode Agbede, Peju Adenusi and 4 more

Open access · goldAbstract read
In one paragraph

Article in BMC health services research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 4 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 4 syntheses or guidelines pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Aina O OdusolaDepartment of Global Health, Academic Medical Center, University of Amsterdam, Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands. A.O.Odusola@amc.uva.nl.
Marleen HendriksDepartment of Global Health, Academic Medical Center, University of Amsterdam, Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands. m.hendriks@aighd.org.
Constance SchultszDepartment of Global Health, Academic Medical Center, University of Amsterdam, Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands. schultsz@gmail.com.
Oladimeji A BolarinwaDepartment of Epidemiology and Community Health, University of Ilorin Teaching Hospital, P.M.B. 1459, postal code 240001, Ilorin, Nigeria. drdeji@yahoo.com.
Tanimola AkandeDepartment of Epidemiology and Community Health, University of Ilorin Teaching Hospital, P.M.B. 1459, postal code 240001, Ilorin, Nigeria. akandetm@yahoo.com.
Akin OsibogunDepartment of Community Health, Lagos University Teaching Hospital, P.M.B.12003, Surulere, Lagos, Nigeria. akinosibogun@yahoo.co.uk.
Charles AgyemangDepartment of Public Health, Academic Medical Center, University of Amsterdam, Meibergdreef 9, Amsterdam, 1105 AZ, The Netherlands. c.o.agyemang@amc.uva.nl.
Gbenga OgedegbeDivision of Health and Behavior, Center for Healthful Behavior Change, Department of Population Health, NYU School of Medicine, New York, NY, 10016, USA. Olugbenga.ogedegbe@nyumc.org.
Kayode AgbedeOgo Oluwa Hospital, 64/65 Ahmadu Bello Way, Bacita, Kwara State, Nigeria. agbedejk@yahoo.com.
Peju AdenusiHygeia Community Health Care, Hygeia HMO, 13B Idejo Street, Lagos, Nigeria. dradenusi@hygeiahmo.com.
Joep LangeDepartment of Global Health, Academic Medical Center, University of Amsterdam, Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands. j.lange@aighd.org.
Henk van WeertDepartment of General Practice, Academic Medical Center, University of Amsterdam, Meibergdreef 9, Amsterdam, 1105, AZ, The Netherlands. h.c.vanweert@amc.uva.nl.
Karien StronksDepartment of Public Health, Academic Medical Center, University of Amsterdam, Meibergdreef 9, Amsterdam, 1105 AZ, The Netherlands. k.stronks@amc.uva.nl.
Joke A HaafkensDepartment of General Practice, Academic Medical Center, University of Amsterdam, Meibergdreef 9, Amsterdam, 1105, AZ, The Netherlands. j.a.haafkens@amc.uva.nl.
Amsterdam Institute for Global Health and Development · NL

Funding

Stroke and Cardiovascular Research Training (SCaRT) InstituteD43TW009140 · FIC · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ADANU, RICHARD M K, ALABI, SULYMAN BIODUN · 2011 to 2023
$2.5M
FIC NIH HHS D43 TW009140
6 · The paper itself

Abstract

backgroundUniversal health care coverage has been identified as a promising strategy for improving hypertension treatment and control rates in sub Saharan Africa (SSA). Yet, even when quality care is accessible, poor adherence can compromise treatment outcomes. To provide information for adherence support interventions, this study explored what low income patients who received hypertension care in the context of a community based health insurance program in Nigeria perceive as inhibitors and facilitators for adhering to pharmacotherapy and healthy behaviors.

methodsWe conducted a qualitative interview study with 40 insured hypertensive patients who had received hypertension care for > 1 year in a rural primary care hospital in Kwara state, Nigeria. Supported by MAXQDA software, interview transcripts were inductively coded. Codes were then grouped into concepts and thematic categories, leading to matrices for inhibitors and facilitators of treatment adherence.

resultsImportant patient-identified facilitators of medication adherence included: affordability of care (through health insurance); trust in orthodox "western" medicines; trust in Doctor; dreaded dangers of hypertension; and use of prayer to support efficacy of pills. Inhibitors of medication adherence included: inconvenient clinic operating hours; long waiting times; under-dispensing of prescriptions; side-effects of pills; faith motivated changes of medication regimen; herbal supplementation/substitution of pills; and ignorance that regular use is needed. Local practices and norms were identified as important inhibitors to the uptake of healthier behaviors (e.g. use of salt for food preservation; negative cultural images associated with decreased body size and physical activity). Important factors facilitating such behaviors were the awareness that salt substitutes and products for composing healthier meals were cheaply available at local markets and that exercise could be integrated in people's daily activities (e.g. farming, yam pounding, and household chores).

conclusionsWith a better understanding of patient perceived inhibitors and facilitators of adherence to hypertension treatment, this study provides information for patient education and health system level interventions that can be designed to improve compliance.

trial registrationISRCTN47894401 .

Indexed as

Insurance CoverageInsurance, HealthMedication AdherenceRural PopulationAdultAgedAged, 80 and overFemaleHealth BehaviorHumansHypertensionMaleMiddle AgedNigeriaPerceptionPoverty

Identifiers

PMID25491509
PMCPMC4267751
OpenAlexW2032767440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.